Biological mechanisms of chronic fatigue

Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

(2010) Gabor G. Illei et al.   ARTHRITIS AND RHEUMATISM

Multiple sclerosis-associated fatigue

(2010) Lauren B Krupp et al.   Expert Review of Neurotherapeutics

Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis

(2010) D. van Hoogmoed et al.   RHEUMATOLOGY

Primary Sjogren's syndrome: too dry and too tired

(2010) W. F. Ng et al.   RHEUMATOLOGY

Anti-CD20 treatment in Primary Sjögren’s Syndrome

(2010) K. Isaksen et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

New insights into the experience of fatigue among patients with rheumatoid arthritis: a qualitative study

(2009) S. Nikolaus et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

(2009) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII

(2009) Paula I. Burgos et al.   ARTHRITIS AND RHEUMATISM

Fatigue in primary Sjögren’s syndrome – A link to sickness behaviour in animals?

(2009) Erna Harboe et al.   BRAIN BEHAVIOR AND IMMUNITY

Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue

(2009) Ingrid J. Orre et al.   BRAIN BEHAVIOR AND IMMUNITY

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor

(2009) Jean-Michel Dayer et al.   RHEUMATOLOGY

Fatigue is a reliable, sensitive and unique outcome measure in rheumatoid arthritis

(2009) P. Minnock et al.   RHEUMATOLOGY

Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6‐month course of TNF inhibitors: prospective intervention study and partial economic evaluation

(2009) J. L. Hoving et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study

(2008) S Dass et al.   ANNALS OF THE RHEUMATIC DISEASES

Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review

(2008) U Kalyoncu et al.   ANNALS OF THE RHEUMATIC DISEASES

Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy

(2008) E. Keystone et al.   ARTHRITIS AND RHEUMATISM

Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome

(2008) Barbara Segal et al.   ARTHRITIS AND RHEUMATISM

Cancer-related fatigue

(2008) Patrick C. Stone et al.   EUROPEAN JOURNAL OF CANCER

Behavioral Symptoms in Patients With Breast Cancer and Survivors

(2008) Julienne E. Bower   JOURNAL OF CLINICAL ONCOLOGY

Molecular insights into quorum sensing in Acidithiobacillus ferrooxidans bacteria via molecular modelling of the transcriptional regulator AfeR and of the binding mode of long-chain acyl homoserine lactones

(2008) Laurent Soulère et al.   JOURNAL OF MOLECULAR MODELING

Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones

(2007) N Tsakiri et al.   BRITISH JOURNAL OF PHARMACOLOGY

Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus

(2007) E Harboe et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

From inflammation to sickness and depression: when the immune system subjugates the brain

(2007) Robert Dantzer et al.   NATURE REVIEWS NEUROSCIENCE